30212-52-3 Usage
General Description
2,4-dichloro-6-Methylpyrido[3,2-d]pyriMidine is a chemical compound with the molecular formula C9H6Cl2N2. It is a pyridine derivative with two chlorine atoms and a methyl group attached to the pyrido ring. 2,4-dichloro-6-Methylpyrido[3,2-d]pyriMidine is used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It is known to exhibit biological activity and is being studied for its potential applications in medicine and industry. Additionally, it is important to handle this chemical with care as it may pose hazards to human health and the environment if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 30212-52-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,2,1 and 2 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 30212-52:
(7*3)+(6*0)+(5*2)+(4*1)+(3*2)+(2*5)+(1*2)=53
53 % 10 = 3
So 30212-52-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H5Cl2N3/c1-4-2-3-5-6(11-4)7(9)13-8(10)12-5/h2-3H,1H3
30212-52-3Relevant academic research and scientific papers
8-SUBSTITUTED QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS
-
Page/Page column 113, (2010/09/18)
Provided herein are 8-substituted quinolines and related analogues as sirtuin-modulating compounds of Structural Formula (I) and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.
4-MORPHOLINO-PYRIDO[3,2-D]PYRIMIDINES
-
Page/Page column 59, (2010/04/27)
This invention relates to compounds of Formula (I) as Pi3k inhibitors for treating autoimmune deseases, inflammatory disorders, multiple sclerosis and other deseases like cancers.